Browsing Over 41 Presentations

Sort By
GSK – Molecular profiling in advanced ovarian cancer: What do we know? (ID 7) Industry satellite

Practical considerations in biomarker testing (ID 37)

Lecture Time
11:55 - 12:15
Speakers
  • Xavier Matias-Guiu (Barcelona, Spain)
Session Name
GSK – Molecular profiling in advanced ovarian cancer: What do we know? (ID 7)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
11:30 - 12:30
Authors
  • Xavier Matias-Guiu (Barcelona, Spain)
GSK – Molecular profiling in advanced ovarian cancer: What do we know? (ID 7) Industry satellite

Clinical considerations in treatment decision-making (ID 1)

Lecture Time
11:30 - 11:55
Speakers
  • Charlie Gourley (Edinburgh, United Kingdom)
Session Name
GSK – Molecular profiling in advanced ovarian cancer: What do we know? (ID 7)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
11:30 - 12:30
Authors
  • Charlie Gourley (Edinburgh, United Kingdom)
GSK – Molecular profiling in advanced ovarian cancer: What do we know? (ID 7) Industry satellite

Panel discussion (ID 44)

Lecture Time
12:15 - 12:30
Speakers
  • Xavier Matias-Guiu (Barcelona, Spain)
  • Charlie Gourley (Edinburgh, United Kingdom)
Session Name
GSK – Molecular profiling in advanced ovarian cancer: What do we know? (ID 7)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
11:30 - 12:30
Authors
  • Xavier Matias-Guiu (Barcelona, Spain)
  • Charlie Gourley (Edinburgh, United Kingdom)
Welcome to ESMO Gynae 2021 and Keynote address (ID 4) Keynote

Live welcome by the Scientific Co-Chairs (ID 7)

Lecture Time
12:45 - 12:50
Speakers
  • All Speakers (, Switzerland)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address (ID 4)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Authors
  • All Speakers (, Switzerland)
Welcome to ESMO Gynae 2021 and Keynote address (ID 4) Keynote

Introduction to the Keynote lecture (ID 8)

Lecture Time
12:50 - 12:55
Speakers
  • Susana Banerjee (London, United Kingdom)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address (ID 4)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Authors
  • Susana Banerjee (London, United Kingdom)
Welcome to ESMO Gynae 2021 and Keynote address (ID 4) Keynote

Keynote lecture: DNA damage repair in ovarian cancer and PARP inhibitors resistance (ID 9)

Lecture Time
12:55 - 13:20
Speakers
  • Amit Oza (Toronto, ON, Canada)
Session Name
Welcome to ESMO Gynae 2021 and Keynote address (ID 4)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
12:45 - 13:20
Authors
  • Amit Oza (Toronto, ON, Canada)
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1) Educational session

The role of surgery for newly diagnosed ovarian cancer: Current status and future directions (ID 11)

Lecture Time
13:50 - 14:05
Speakers
  • Sven Mahner (Munich, Germany)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Authors
  • Sven Mahner (Munich, Germany)
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1) Educational session

First line maintenance therapy for ovarian cancer in 2021: What are the options? (ID 12)

Lecture Time
14:05 - 14:20
Speakers
  • Isabelle Ray-Coquard (Lyon, France)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Authors
  • Isabelle Ray-Coquard (Lyon, France)
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1) Educational session

Horizon scanning: What’s next for systemic therapy in ovarian cancer - first line and beyond? (ID 13)

Lecture Time
14:20 - 14:35
Speakers
  • Domenica Lorusso (Rome, Italy)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Authors
  • Domenica Lorusso (Rome, Italy)
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1) Educational session

Live Q&A and discussion (ID 14)

Lecture Time
14:35 - 14:50
Speakers
  • All Speakers (, Switzerland)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Authors
  • All Speakers (, Switzerland)
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1) Educational session

The evolving role of molecular profiling for therapeutic stratification in newly diagnosed ovarian cancer (ID 10)

Lecture Time
13:35 - 13:50
Speakers
  • David SP Tan (Singapore, Singapore)
Session Name
Treatment of newly diagnosed ovarian cancer: Where are we in 2021 and what’s next? (ID 1)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
13:35 - 14:50
Authors
  • David SP Tan (Singapore, Singapore)
1st line maintenance strategy options for advanced ovarian cancer by HRD profile (ID 8) Clinical case session

Clinical case - What options for HR proficient patients? Criteria for treatment choice (ID 16)

Lecture Time
15:25 - 15:45
Speakers
  • Nicoletta Colombo (Milan, Italy)
Session Name
1st line maintenance strategy options for advanced ovarian cancer by HRD profile (ID 8)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
15:05 - 16:20
Authors
  • Nicoletta Colombo (Milan, Italy)